Bayer | BAYN - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Air Liquide EUR 10.93B 561.2M 2026-06
Akzo Nobel EUR 2.61B 273M 2026-09
Alcon AG USD 2.78B 370M 2026-06
Amarin USD 51.48M 113K 2025-12
Arkema EUR 2.24B 800K 2026-09
AstraZeneca USD 11.55B 674M 2026-09
BASF EUR 16.49B 719M 2026-09
Bayer EUR 9.92B 121M 2026-09
Beiersdorf EUR 4.19B 32M 2026-06
Corteva USD 4.43B 678.08M 2026-06
Covestro EUR 3.24B 5.46B 2025-12
Essilor EUR 12.52B 568M 2026-06
Fresenius EUR 5.24B 19M 2026-09
Fresenius Medical Care EUR 4.55B 229.7M 2026-09
Genmab DKK 748M 77M 2026-06
Givaudan CHF 3B 107M 2025-12
GlaxoSmithKline GBP 6.03B 227M 2026-09
GRIFOLS EUR 1.65B 101M 2026-09
Henkel EUR 8.7B 35M 2026-06
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Johnson Matthey GBP 7.02B 1.81B 2026-06
Linde USD 6.86B 451M 2026-09
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.34B 249M 2026-06
Novartis USD 9.88B 325M 2026-09
Nutrien USD 5.42B 3.54B 2026-09
Philips EUR 4.23B 478M 2026-09
PPG Industries USD 3.7B 154M 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09
SAP EUR 9.34B 2.11B 2026-09
Solvay EUR 1.06B 8M 2026-09
UCB EUR 2.96B 196M 2025-12
Umicore EUR 27.12B 17.15B 2026-06
Vinci EUR 32.03B 2.09B 2026-06